Secukinumab Use in Patients With Moderate-To-Severe Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data From SERENA Study
posted on 2020-05-04, 12:13authored byUta Kiltz, Petros P. Sfikakis, Karl Gaffney, Paul-Gunther Sator, Ralph von Kiedrowski, Andreas Bounas, Nicola Gullick, Curdin Conrad, Dimitris Rigopoulos, Eric Lespessailles, Marco Romanelli, Pierre-Dominique Ghislain, Jan Brandt-Jürgens, Rasho Rashkov, Maher Aassi, Roberto Orsenigo, Chiara Perella, Effie Pournara, Sven Gathmann, Piotr Jagiello, Justyna Veit, Matthias Augustin
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).